risperdal

Tylenol and Band-Aid maker Johnson & Johnson announced on Tuesday that its sales declined 0.7% to $15 billion in the third quarter, compared to the same quarter last year, as domestic sales were "significantly impacted" by recent successive recalls. Domestic sales declined 2.5%.

Johnson & Johnson shares are rebounding as the drug maker recovers from federal charges it paid kickbacks to a pharmacy company to boost sales of its drugs to nursing-home patients. Meantime, the Food and Drug Administration accused it of being too slow with its product recall during a Tylenol scare.

It was just at the end of October that the Journal of the American Medical Association published a study which found that children taking the latest generation of antipsychotic drugs gain significant amounts of weight -- as much as 18.7 pounds on average in just 11 weeks. Young people taking Eli...